Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Bispebjerg Hospital.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Bispebjerg Hospital
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT01349361
First received: May 5, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | May 5, 2011 | ||||
| Last Updated Date | May 5, 2011 | ||||
| Start Date ICMJE | March 2011 | ||||
| Primary Completion Date | January 2013 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
complete disappearance of the BCC | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight | ||||
| Official Title ICMJE | Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight | ||||
| Brief Summary | Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 2 | ||||
| Study Design ICMJE | Not Provided | ||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Procedure: Daylight mediated photodynamic therapy | ||||
| Study Arm (s) | Experimental: Daylight-PDT
Intervention: Procedure: Daylight mediated photodynamic therapy |
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Enrollment ICMJE | Not Provided | ||||
| Completion Date | Not Provided | ||||
| Primary Completion Date | January 2013 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | Not Provided | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Denmark | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01349361 | ||||
| Other Study ID Numbers ICMJE | 2010-024517-31 | ||||
| Has Data Monitoring Committee | Not Provided | ||||
| Responsible Party | Hans Christian Wulf, Bispebjerg Hospital | ||||
| Study Sponsor ICMJE | Bispebjerg Hospital | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE | Not Provided | ||||
| Information Provided By | Bispebjerg Hospital | ||||
| Verification Date | March 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||